Records containing: Weight Management
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-13A Multicenter, Randomized, Open-label, Treatment Switching Phase II Study to Evaluate the Efficacy and Safety of XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity
-
CLINICAL_TRIALS study record update · 2026-04-06To Evaluate a Multicenter, Randomized, Open, Positive Parallel Controlled Phase III Clinical Trial of Semaglutide Injection (HD1916) in the Treatment of Obesity
-
CLINICAL_TRIALS study record update · 2026-04-01A Phase 2a, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of ECC4703 as an Adjunct to Semaglutide in Adults With Obesity
-
CLINICAL_TRIALS study record update · 2026-03-31Improving Cardiovascular Disease Risk Factors in Survivors of Adolescent and Young Adult Cancer With Obesity: Adaptation and Pilot Testing of a Behavioral Weight and Symptom Management Intervention
-
CLINICAL_TRIALS study record update · 2026-03-17A Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Oral Doses of GS-4571 in Healthy Participants, Multiple Ascending Oral Doses of GS-4571 in Nondiabetic Obese Participants and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM), and to Evaluate the Effect of Food and an Acid-Reducing Agent on Pharmacokinetics of GS-4571
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-05Effect of a Reducose®-Based Supplement in Subjects With Metabolic Syndrome: Impact on Cardiometabolic Parameters and Chronic Liver Disease
-
CLINICAL_TRIALS study record update · 2026-02-25Increasing Access to USPSTF-Recommended Obesity Care for Youth and Adults Who Are Recipients of Medicaid: Evaluation of a Comprehensive Multidisciplinary Obesity Care Training Program in FQHCs
-
CLINICAL_TRIALS study record update · 2026-02-23Development and Pilot Testing of a Novel Intervention to Reduce Cardiovascular Disease Risk Among Breast Cancer Survivors Living in Rural, Medically Underserved Communities
-
CLINICAL_TRIALS study record update · 2026-02-04Dose-ranging Double-blind, Placebo-controlled Phase 2 Trial of GV101 for Weight Loss in Healthy Obese Participants
-
CLINICAL_TRIALS study record update · 2026-01-28A Multicenter, Multiple-dose Escalation, Randomized, Double-blind, Placebo-controlled Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
-
CLINICAL_TRIALS study record update · 2025-12-23Usability Study of Gestational and 6 Months Postpartum Weight Management Program - Hope D
-
CLINICAL_TRIALS study record update · 2025-12-19Tolerance and Appetite Reduction of a Nutritional Solution With Intragastric Gelation Properties
-
CLINICAL_TRIALS study record update · 2025-11-06Efficacy And Safety of KSM66 Ashwagandha (Withania Somnifera) Standardized Root Extract (300 mg) on Weight and Stress Management in Overweight and Obese Adults: A Prospective, Randomized, Double-Blind Placebo- Controlled Study
-
CLINICAL_TRIALS study record update · 2025-10-27Enacting Active Survivorship: Implementation of Weight Management Strategies in Endometrial Cancer Survivors
-
CLINICAL_TRIALS study record update · 2025-08-07Feasibility, Acceptability, and Validation of a User-friendly Diet Quality Tool in Adults From Ambulatory Nutrition Clinics: the PLATE Study
-
CLINICAL_TRIALS study record update · 2025-08-06A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of YP05002 in Healthy Participants
-
CLINICAL_TRIALS study record update · 2025-07-30Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures: For Use in Healthy Individuals Ages 18-65 Who Seek to Improve Their Health and Longevity Through Low-dose (Microdosed) GLP1 Receptor Agonists
-
CLINICAL_TRIALS study record update · 2025-07-24The Acute Effects of an Endurance Exercise Bout the Gut Microbiome and Gut-derived Metabolome in Women's Distinct Fitness and Body Mass Indexes
-
CLINICAL_TRIALS study record update · 2025-07-24Identifying the Short-Term Neurobiological, Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With Obesity: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial
-
CLINICAL_TRIALS study record update · 2025-07-04Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity (MODERN)
-
CLINICAL_TRIALS study record update · 2025-06-18Exploring the Impact of Mindful Eating: A Pilot Study Among Breast Cancer Survivors in Türkiye
-
CLINICAL_TRIALS study record update · 2025-05-25ClinicalTrials.gov study NCT01030354
-
CLINICAL_TRIALS study record update · 2025-05-20A Phase I Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASC30 Tablets in Participants With Obesity
-
CLINICAL_TRIALS study record update · 2025-05-13How to Prevent Lost in Transition? - Adaptive Randomised Controlled Trial of a Self-management Based Survivorship Intervention for Chinese Cancer Survivors
-
CLINICAL_TRIALS study record update · 2025-04-30A Phase 3, Multi-center, Randomized, Double-Blind and Placebo-controlled Study to Evaluate the Efficacy and Safety of XW003 in Adults With Overweight or Obesity (SLIMMER)